Green Pine Capital Partners
China energy storage player Weview raises $87m
Weview, a China-based battery manufacturer, has raised a Series A of CNY 600m (USD 87m) led by two state-backed investors - Guohe Xinli, which is a fund under the State Development & Investment Corporation (SDIC) and Zhuhai-based Da Heng Qin Group.
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
China semiconductor equipment player raises $139m
Dongfang Jingyuan Electron (DJEL), a China-based semiconductor equipment and software provider, has raised CNY 1bn (USD 139m) from an investor group that includes Green Pine Capital Partners and CoStone Capital.
Gaorong backs China energy storage company
China-based energy storage company WeView has raised CNY 400 million (USD 57m) from a group including Gaorong Capital, Green Pine Capital Partners, and ZhenFund.
Fengshi leads $45m Series D for China cancer diagnosis player
Singlera Genomics, a Shanghai-based cancer diagnostics specialist, has raised an extended Series B round of CNY 300m (USD 45m) led by Fengshi Investment Management.
China chip developer Hongjun raises $120m
Chinese chip developer Hongjun Microelectronics has raised CNY 800m (USD 120m) in angel and pre-Series A rounds led by Walden International, GL Ventures, and CDH Venture and Growth Capital.
China 5G chip designer Cygnus raises $100m
Chinese 5G chip design company Cygnus Semiconductor has raised USD 100m in Series A funding and an extended pre-Series A round led by Matrix Partners China and Wofo Capital.
CPE leads $150m Series B for China CDMO
Joinn Biologics, a China-based contract development and manufacturing organization (CDMO), has raised $150 million in Series B funding led by CPE.
Hong Kong industrial AI start-up raises $200m
SmartMore, a Hong Kong-headquartered artificial intelligence (AI) and computer vision start-up, has achieved unicorn status after raising $200 million in Series B funding.
Chinese pharmaceutical platform Yaoshibang raises $270m
Chinese B2B pharmaceutical trading platform Yaoshibang has raised $270 million from Guangdong Pearl River Investment, Baidu, Sunshine Insurance, Green Pine Capital Partners, Guangzhou government-backed S Fund, and an undisclosed sovereign wealth fund.
China chip IP specialist Akrostar raises $78m
Akrostar, a Chinese chip designer established less than a year ago by a team that spun out from US-headquartered industry leader Synopsys, has raised RMB500 million ($78 million) in Series A funding.
Lilly Asia leads $90m round for China's Duality Biologics
Lilly Asia Ventures has led a $90 million Series B round for Duality Biologics, a Chinese developer of oncology and autoimmune drugs.
3H Health leads $67m Series B for China's EdiGene
China’s 3H Health Investment has led a RMB450 million ($67 million) Series B round for local genetics-based drug discovery and therapeutics developer EdiGene.
PE-backed Kintor Pharma raises $240m in Hong Kong IPO
Kintor Pharmaceutical, a Chinese drug developer backed by the likes of HighLight Capital and Shenzhen Green Pine Capital Partners, posted a 7% gain on debut following a HK$1.86 billion ($240 million) Hong Kong IPO.
China AI player 4Paradigm closes $230m Series C
4Paradigm, a Chinese artificial intelligence (AI) start-up, has raised about $80 million in an extended Series C round, bringing its valuation to more than $2 billion.
Coronavirus in China: Back from the brink
China GPs are trying to navigate the coronavirus uncertainty and help portfolio companies pick up the pieces, whether that means cutting costs or realizing new revenue streams
Green Pine leads Series B for Chinese gene testing player
Chinese gene testing business AmCare Genomics Lab has raised RMB110 million ($16 m) in Series B funding led by Green Pine Capital Partners. This comes four months after the company closed an extended Series A round of RMB30 million.
Jeneration leads round for China data security provider
DataCloak, a Shenzhen-based data security start-up that employs the zero-trust approach, has raised $13 million in Series A funding led by Jeneration Capital.
Co-Stone leads $28m Series B for Chinese gene sequencer
Gene+ Technology, a Chinese provider of gene sequencing services used to support cancer diagnoses, has raised RMB200 million ($28 million) in a Series B round led by Co-Stone Asset Management.
China autonomous driving start-up receives $50m pre-A
DeepRoute, a Shenzhen-based autonomous driving solutions provider, has received $50 million in a pre-A funding round led by Fosun RZ Capital.
Green Pine raises $140m for RMB tech fund
Shenzhen Green Pine Capital Partners (GPCP) has raised RMB1 billion ($140 million) for a fund that will target artificial intelligence (AI), robotics and internet of things (IoT) investments in China.
China tech board makes volatile debut
The initial batch of companies chosen to list on China’s technology innovation board – known as the Star Market – posted an average gain of 140% on their first day of trading on July 22, although almost all were pared back in the opening hours of...
Chinese fintech player Wiseco raises $94m Series A
Chinese financial technology start-up Wiseco Technology, which provides big data-powered risk control and debt collection services, has raised RMB650 million ($94 million) in a Series A round led by Huading Capital and Sino Ocean Group.
Chinese gene tech equipment maker raises $200m
MGI Tech, a Chinese manufacturer of equipment used in gene sequencing, has raised $200 million in funding led by Goldstone Investment, the PE arm under CITIC Securities, Green Pine Capital Partners and Orient Securities Capital Investment.